Differently from classic SS, where a sarcomatous component is present; greater benefits are obtained if the treatment includes radiotherapy and adjuvant chemotherapy in addition to
radical inguinal orchiectomy (3,6).
The risk of relapse after
radical inguinal orchiectomy alone is estimated to be 1 3-20% at five years, (15-18) but long-term cure rates approach 100%.
A left
radical inguinal orchiectomy was performed and the specimen was submitted for histopathological examination.
The standard treatment for all testicular tumors in adults is
radical inguinal orchiectomy. In the setting of a pure teratoma with advanced disease and elevation of tumor markers, chemotherapy is the systemic therapy of choice [14].
He was two months status post
radical inguinal orchiectomy for right testicular mature teratoma with retroperitoneal and mediastinal nodal metastases, with no follow up after surgery because of a lack of health insurance.
Radical inguinal orchiectomy followed by retroperitoneal lymph node dissection is recommended for all children over the age of 10 and for those younger than 10 years old with the retroperitoneal disease.
As per Coleman et al, the accepted treatment for para-testicular sarcoma is
radical inguinal orchiectomy. Patients with an initial incomplete resection should undergo repeat wide excision.
Radical inguinal orchiectomy is the standard surgical approach for yolk sac tumors.
A
radical inguinal orchiectomy is the procedure of choice in treating a malignant testicular mass (NCI, 2008b).
(1-3) Although standard therapy for testicular cancer is
radical inguinal orchiectomy, in patients with bilateral tumours or tumour in a solitary testis, orchiectomy will lead to infertility and hormonal deficiency.
The patient underwent left
radical inguinal orchiectomy without complications.
Ten years later, he was found to have a left testicular mass and underwent a left
radical inguinal orchiectomy revealing a malignant teratoma.